2012
Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer
YUN S, JEONG P, KIM W, KIM T, LEE Y, SONG P, CHOI Y, KIM I, MOON S, KIM W. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. International Journal Of Oncology 2012, 41: 1871-1878. PMID: 22961325, DOI: 10.3892/ijo.2012.1622.Peer-Reviewed Original ResearchConceptsBladder cancerCell-free miRNAsMiR-200aMiR-145Transitional cell carcinomaBladder cancer patientsNon-cancer controlsHealthy normal controlsMiR-145 levelsMiR-200a levelsCell-free microRNAsNMIBC recurrenceIndependent predictorsClinicopathological featuresCell carcinomaCancer patientsPrognostic biomarkerUrinary bladderHigh riskNoninvasive biomarkersNormal controlsAccurate biomarkersMultivariate analysisPatientsCancer
2009
Ureteral Fibrin Sealant Injection of the Distal Ureter During Laparoscopic Nephroureterectomy—A Novel and Simple Modification of the Pluck Technique
Mueller T, DaJusta D, Cha D, Kim I, Ankem M. Ureteral Fibrin Sealant Injection of the Distal Ureter During Laparoscopic Nephroureterectomy—A Novel and Simple Modification of the Pluck Technique. Urology 2009, 75: 187-192. PMID: 19913884, DOI: 10.1016/j.urology.2009.06.101.Peer-Reviewed Original ResearchConceptsFibrin sealant injectionDistal ureterLaparoscopic nephroureterectomyPostoperative dayUreteral orificeUpper tract transitional cell carcinomaTract transitional cell carcinomaAverage operative timeTransitional cell carcinomaCollins knifeIntravesical recurrenceMean cancerNormal cystogramPluck techniqueUreteral blockageTumor spillageMinor complicationsBlood lossMedian ageOperative timeFoley catheterUreteral obstructionBladder tumorsCell carcinomaSpecimen margins
2006
Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue
Shen S, Smith C, Hsieh J, Yu J, Kim I, Jian W, Sonpavde, Ayala G, Younes M, Lerner S. Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue. Cancer 2006, 106: 2610-2616. PMID: 16700038, DOI: 10.1002/cncr.21945.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic AgentsBlotting, WesternCarcinoma, Transitional CellCell Line, TumorCell ProliferationEstradiolEstrogen Receptor alphaEstrogen Receptor betaFulvestrantGene Expression ProfilingGene Expression Regulation, NeoplasticHumansImmunohistochemistryMicroarray AnalysisNeoplasm StagingRaloxifene HydrochlorideReverse Transcriptase Polymerase Chain ReactionRNA, MessengerTamoxifenUrinary Bladder NeoplasmsConceptsBladder cancer cell linesExpression of ERbetaCancer cell linesERbeta expressionHuman bladder cancerBladder cancer cellsBladder cancerEstrogen receptorWestern blot analysisT4 tumorsCell linesMetastatic transitional cell carcinomaMuscle-invasive bladder cancerER-alpha mRNA levelsT3/T4 tumorsHuman bladder tumor tissuesRT4 cellsBladder cancer cell growthLevels of ERalphaGrade 3 tumorsCancer cellsInvasive bladder cancerTa/T1Transitional cell carcinomaEffects of estradiol
2001
Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma
Shariat S, Kim J, Andrews B, Kattan M, Wheeler T, Kim I, Lerner S, Slawin K. Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma. Cancer 2001, 92: 2985-2992. PMID: 11753975, DOI: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5.Peer-Reviewed Original ResearchConceptsMuscle-invasive transitional cell carcinomaTransitional cell carcinomaT1 transitional cell carcinomaPreoperative plasma levelsPlasma TGFDisease recurrenceIndependent predictorsLymph nodesClinical outcomesPlasma levelsBladder carcinomaGrowth factorDisease-specific mortalityDisease-specific survivalRegional lymph nodesSubgroup of patientsStrong independent predictorGrowth factor-β1Intravesical immunoCarcinoma metastaticLymphovascular invasionSpecific survivalRadical cystectomyPathologic featuresCell carcinomaPredictive value of expression of transforming growth factor‐β1 and its receptors in transitional cell carcinoma of the urinary bladder
Kim J, Shariat S, Kim I, Menesses‐Diaz A, Tokunaga H, Wheeler T, Lerner S. Predictive value of expression of transforming growth factor‐β1 and its receptors in transitional cell carcinoma of the urinary bladder. Cancer 2001, 92: 1475-1483. PMID: 11745225, DOI: 10.1002/1097-0142(20010915)92:6<1475::aid-cncr1472>3.0.co;2-x.Peer-Reviewed Original ResearchConceptsTransitional cell carcinomaBladder transitional cell carcinomaInvasive tumor stageOverexpression of TGFDisease progressionIndependent predictorsCell carcinomaTumor stageLoss of expressionTGF betaGrowth factorDisease-specific survivalAltered expressionExpression of TGFGrowth factor-β1Lymphovascular invasionRadical cystectomySpecific survivalClinical outcomesCystectomy specimensUrinary bladderImmunohistochemical stainingBlinded fashionFactor-β1Predictive value
1998
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee D, Yang S, Hong S, Chung B, Kim I. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Clinical Cancer Research 1998, 4: 535-8. PMID: 9533519.Peer-Reviewed Original ResearchConceptsTransitional cell carcinomaBladder transitional cell carcinomaBladder washesCell carcinomaCytological diagnosisTelomerase activityGrade 1 transitional cell carcinomaCancer tissuesNormal tissuesHuman bladder cancer tissuesBladder wash samplesPositive telomerase activityFinal pathological diagnosisLow-grade tumorsBladder cancer tissuesTelomeric repeat amplificationPositive cytologyTransurethral resectionBladder tumorsBladder cancerPathological diagnosisWash samplesCytological specimensPatientsPotential marker
1997
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes
Yang S, Lee D, Hong S, Chung B, Kim I. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes. Yonsei Medical Journal 1997, 38: 155-159. PMID: 9259615, DOI: 10.3349/ymj.1997.38.3.155.Peer-Reviewed Original ResearchConceptsTransitional cell carcinomaTelomeric repeat amplification protocolWash specimensBladder cancerBladder wash specimensCancer tissuesCell carcinomaCytologic diagnosisTelomerase activityCytopathologic diagnosisGrade 1 transitional cell carcinomaNormal tissuesBladder transitional cell carcinomaHuman bladder cancer tissuesBladder wash cytologyFinal pathologic diagnosisBladder cancer tissuesRepeat amplification protocolPolymerase chain reaction techniqueTransurethral resectionChain reaction techniquePathologic diagnosisBladder washesSame patientGrade 2